Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key ...

Creative Biolabs is proud to announce an upcoming industry webinar on engineered human 3D brain tissues for neurodegenerative disease modeling.

Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...

For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

The clearest evidence came after the researchers depleted the microglia. Mice with Alzheimer’s related pathology slept more ...

We are excited to back brilliant researchers as they seek answers to some of the most urgent questions in healthcare New Zealand’s neuroscience community has just received a $3.4 million injection ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in ...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

Unlike accidental cell death, some cells can actively decide to die through a controlled process. This is called programmed cell death and can occur in different forms, including apoptosis and ...